AGF Management’s Halozyme HALO Stock Holding History

AGF Management’s Portfolio HALO Stock Details HALO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-51,831	Closed	-$3.35M	–	694
2026 Q1	$3.35M	Buy	51,831 +8,847	+21%	+$624K	0.02%	391
2025 Q4	$2.89M	Buy	+42,984	New	+$2.89M	0.01%	422

Other funds holding HALO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

AGF Management's HALO Position: Q2 2026 in Review

AGF Management sold out of Halozyme (HALO) in Q2 2026, closing a stake of 51,831 shares — an estimated $3.35M sold.

AGF Management first reported a position in HALO in Q4 2025 and held it in 2 quarters. The position peaked at $3.35M in Q1 2026. 671 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

AGF Management reported no remaining Halozyme position as of Q2 2026 after selling out during the quarter.
AGF Management sold 51,831 Halozyme shares in Q2 2026, an estimated $3.35M.
AGF Management first reported a position in Halozyme in Q4 2025 and held it in 2 quarters.
AGF Management's Halozyme position peaked at $3.35M in Q1 2026.
671 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on AGF Management's 13F filing for Q2 2026, filed 10 Aug 2026.